A pharmacy in the city
of Hamilton, Ontario has
denied allegations of diluting
chemotherapy drugs, after an
investigation found that more than
1000 cancer patients across the
region received doses about 20%
lower than prescribed.
Marchese Health Care, which
supplied the chemotherapy drugs
to several hospitals in the region,
instead blamed the “manner
of administration used in some
hospitals that was not aligned with
how the standardised preparation
had been contractually specified”.
Cancer Care Ontario is probing
the matter in which 1076
patients received lower doses of
gemcitabine and cyclophosphamide
over the last 12 months.
A law firm has already been
retained in connection with a class
action lawsuit over the controversy.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Apr 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Apr 13
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.